G Milne, T Hames, C Scotton, N Gent… - The Lancet …, 2021 - thelancet.com
Many nations are pursuing the rollout of SARS-CoV-2 vaccines as an exit strategy from unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
Background Assessment of viral kinetics of SARS-CoV-2 can inform on host immune responses to the virus and on the viral transmission potential. We aimed to characterise viral …
A key unsolved question in the current coronavirus disease 2019 (COVID-19) pandemic is the duration of acquired immunity. Insights from infections with the four seasonal human …
AA Butt, P Yan, OS Shaikh, FB Mayr - EClinicalMedicine, 2021 - thelancet.com
Background Breakthrough infections after SARS-CoV-2 infection have been reported. Clinical outcomes among persons with breakthrough infection are not known. Methods We …
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with a range of persistent symptoms impacting everyday functioning, known as post-COVID-19 …
D Ayoubkhani, ML Bosworth, S King… - Open Forum …, 2022 - academic.oup.com
We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has differential effects according to age, with symptomatic and severe infections mostly occurring in older adults …
Background We estimated the prevalence of long COVID and impact on daily living among a representative sample of adults in the United States. Methods We conducted a population …
P Venkatesan - The Lancet Respiratory Medicine, 2022 - thelancet.com
On Jan 6, 2022, the UK Government's Office of National Statistics (ONS) published their latest report on the prevalence of long COVID in the UK from a representative survey. As of …